The Role of the Tumor Microenvironment in Glioblastoma: A Mathematical Model

Glioblastoma multiforme is one of the deadliest human cancers and is characterized by tumor cells that hijack immune system cells in a deadly symbiotic relationship. Microglia and glioma infiltrating macrophages, which in principle should mount an immune response to the tumor, are subverted by tumor cells to facilitate growth in several ways. In this study, we seek to understand the interactions between the tumor cells and the microglia that enhance tumor growth, and for this purpose, we develop a mathematical and computational model that involves reaction-diffusion equations for the important components in the interaction. These include the densities of tumor and microglial cells, and the concentrations of growth factors and other signaling molecules. We apply this model to a transwell assay used in the laboratory to demonstrate that microglia can stimulate tumor cell invasion by secreting the growth factor TGF- $\beta$. We show that the model can both replicate the major components of the experimental findings and make new predictions to guide future experiments aimed at the development of new therapeutic approaches. Sensitivity analysis is used to identify the most important parameters as an aid to future experimental work. This study is the first step in a program that involves development of detailed 3-D models of the mechanical and biochemical interactions between a glioblastoma and the tumor microenvironment.

[1]  B. Teicher,et al.  TGF-beta in cancer and as a therapeutic target. , 2006, Biochemical pharmacology.

[2]  A. Sica,et al.  Macrophage plasticity and polarization in tissue repair and remodelling , 2013, The Journal of pathology.

[3]  J. Segall,et al.  Review: molecular mechanism of microglia stimulated glioblastoma invasion. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[4]  J. Kuratsu,et al.  Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas , 2008, The Journal of pathology.

[5]  Avner Friedman,et al.  Mechanistic modeling of the effects of myoferlin on tumor cell invasion , 2011, Proceedings of the National Academy of Sciences.

[6]  H. Othmer,et al.  A HYBRID MODEL FOR TUMOR SPHEROID GROWTH IN VITRO I: THEORETICAL DEVELOPMENT AND EARLY RESULTS , 2007 .

[7]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[8]  Hans G Othmer,et al.  A Hybrid Model of Tumor–Stromal Interactions in Breast Cancer , 2013, Bulletin of Mathematical Biology.

[9]  Helmut Kettenmann,et al.  The role of microglia and macrophages in glioma maintenance and progression , 2015, Nature Neuroscience.

[10]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[11]  Yukio Fujiwara,et al.  Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. , 2016, Advanced drug delivery reviews.

[12]  Yangjin Kim,et al.  Strategies of Eradicating Glioma Cells: A Multi-Scale Mathematical Model with MiR-451-AMPK-mTOR Control , 2015, PloS one.

[13]  G. Pilkington,et al.  Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. , 1994, British Journal of Cancer.

[14]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[15]  K. Toyka,et al.  In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells , 1994, Neuroscience Letters.

[16]  D. Steindler,et al.  Chondroitin Sulfate Proteoglycans Potently Inhibit Invasion and Serve as a Central Organizer of the Brain Tumor Microenvironment , 2013, The Journal of Neuroscience.

[17]  Avner Friedman,et al.  A mathematical model for pattern formation of glioma cells outside the tumor spheroid core. , 2009, Journal of theoretical biology.

[18]  P. Schedin,et al.  Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. , 2000, Cancer research.

[19]  J. Segall,et al.  Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling , 2012, Molecular medicine.

[20]  T. Jiang,et al.  MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas , 2011, Journal of Neuro-Oncology.

[21]  E. Castrén,et al.  Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation , 1992, The Journal of cell biology.

[22]  B. Teicher,et al.  TGF-β in cancer and as a therapeutic target , 2006 .

[23]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[24]  Nico van Rooijen,et al.  Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.

[25]  J. Pollard Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.

[26]  J. Yong,et al.  Effective permeability of the boundary of a domain , 1995 .

[27]  Qi-En Wang,et al.  Review Article TGF-β signaling and its targeting for glioma treatment , 2015 .

[28]  F. Heppner,et al.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.

[29]  H. Lee,et al.  The role of the microenvironment in regulation of CSPG-driven invasive and non-invasive tumor growth in glioblastoma , 2015 .

[30]  A. Wesołowska,et al.  Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor , 2008, Oncogene.

[31]  Peng Zhang,et al.  Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway , 2012, The Journal of Immunology.

[32]  A. Wesołowska,et al.  Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. , 2008, Oncogene.